3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Pancreatic Neoplasms
15
Neoplasms
11
Multiple Myeloma
9
Colorectal Neoplasms
8
Myelodysplastic Syndromes
7
Leukemia, Myeloid, Acute
6
Glioblastoma
5
Sarcoma
4
Prostatic Neoplasms
4
Neoplasms, Plasma Cell
4
Leukemia, Myelomonocytic, Chronic
4
Carcinoma, Non-Small-Cell Lung
4
Inflammation
3
Breast Neoplasms
3
Stomatitis
2
Stomach Neoplasms
2
Skin Neoplasms
2
Primary Myelofibrosis
2
Ovarian Neoplasms
2
Neoplasms by Site
2
Myofibroma
2
Myeloproliferative Disorders
2
Lymphoma
2
Lung Neoplasms
2
Liver Neoplasms
2
Leukemia
2
Glioma
2
Frailty
2
Digestive System Neoplasms
2
Digestive System Diseases
2
Interventions
Metformin
7
Surveys and Questionnaires
3
Nutrition Assessment
3
Exercise
3
Tirzepatide
2
Therapeutics
2
Tablets
2
Standard of Care
2
Specimen Handling
2
Resistance Training
2
Methods
2
Interviews as Topic
2
Glucose Tolerance Test
2
Educational Status
2
Biopsy
2
tocilizumab
1
tislelizumab
1
pembrolizumab
1
epalrestat
1
donafenib
1
amlodipine, atorvastatin drug combination
1
Verapamil
1
Urine Specimen Collection
1
Testosterone
1
Secretin
1
Second Harmonic Generation Microscopy
1
Risk Assessment
1
Remote Consultation
1
Preventive Health Services
1
Practice Guidelines as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Diabetes Mellitus
×
Ascorbic Acid
×
Clear all
NCT00786019
2023-07-12
InsITE
University of Colorado, Denver
Phase NA
Completed
47 enrolled
22 charts